| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0128b1ea25bace77f9ff5dc6b2210d7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0812 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 |
| filingDate |
2008-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69586642ba4ec4da0ddb412ca56ae5af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_367af2291cf958f94dd6da51089f9b60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bf7924a81a6b92eba3c1ae1e9bf1e4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d691a375ac80a8724f48b518f8489c78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a8ad2b919370673fbadc2266fbbfb6f |
| publicationDate |
2010-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010292219-A1 |
| titleOfInvention |
Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| abstract |
The present invention provides tertiary amine substituted peptides of Formula (I) useful as inhibitors of HCV replication. The variables R and R 1 -R 12 in Formula I are described herein. The invention also includes methods for preparing such compounds. The present invention further includes pharmaceutical compositions containing tertiary amine substituted peptides and methods for using such compounds, including methods for using the compounds to treat hepatitis C infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201541-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201584-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014153113-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014153113-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8937041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105365-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103664739-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103664739-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9309279-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9333204-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014033667-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8951964-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9744170-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420596-B2 |
| priorityDate |
2007-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |